Market Overview

• A nicotine patch is a device that delivers nicotine into the body through the skin. This patch is usually used to help prevent nicotine cravings that smokers experience when trying to quit smoking. A nicotine patch is a product used for nicotine replacement therapy (NRT). These transdermal patches are exclusively used for smoking cessation. This patch is stick on the body, where nicotine is released from the patch and is absorbed by the skin. Released nicotine binds to nicotine receptors in the body, by reducing craving and symptoms related to smoking cessation. It helps people stop smoking cigarettes. The nicotine patches such as NicoDerm CQ are used. It releases controlled and low quantities of nicotine, without the release of harmful ingredients found in tobacco such as carbon monoxide and tar.

Market Dynamics
• The global Nicotine Patch Market is primarily driven due to rising awareness amongst the population regarding smoking health hazard and increasing research and development. On the other hand, the factor that is restraining overall market growth is side effects of the nicotine patch. The nicotine patch is easy to use and gives you Nicotine all day (although it releases Nicotine a bit slower than the mouth spray, lozenge, gum or inhalator). After putting the patch on, it can take hours to absorb the
• Various anti-smoking initiatives and campaigns are being launched and conducted by organizations to create awareness. Smoking cessation aids, including nicotine patches, are gaining popularity among consumers, which will considerably drive market growth during the forecast period.
• However, side effects of nicotine patches are projected to restrain the global nicotine transdermal patches market during the forecast period.

Market Segmentation
• By product, the global nicotine patch market is segmented into 16-hour nicotine patch and 24-hour nicotine patch. The 24-hour Nicotine Patch is dominating the market in 2018 with the highest share in 2018. Both patches decreased morning smoking urges, although results are significantly superior for the 24-hr patch. Furthermore, the 24-hr patch is more effective than the 16-hr patch in reducing the positive reinforcing dimension of smoking urges. The 24-hr nicotine patch formulation is more effective than the 16-hr formulation in alleviating morning smoking urges and more specifically, the decisive reinforcing factor.
• Habitrol by Dr. Reddy’s Laboratories Ltd. is a nicotine patch that uses time-release technology to curb withdrawal symptoms and with behavior support program increases your chances of quitting. The Habitrol patch replaces some of the nicotine that your body would otherwise get from smoking—without the other harmful chemicals found in cigarette smoke. With a patch, the withdrawal symptoms many feel while kicking the habit are diminished.

Geographical Analysis
By geography, the global Nicotine Patch market is segmented into
• North America,
• Asia-Pacific (APAC),
• Europe,
• South America,
• Middle East
• and Africa (MEA).

Competitive Analysis
Major players in the market are
• Dr. Reddy’s Laboratories Ltd.,
• GlaxoSmithKline plc.,
• Johnson & Johnson Services, Inc.,
• Novartis AG,
• Others


View full sample report: https://www.datamintelligence.com/research-report/nicotine-patch-market

Download free sample: https://www.datamintelligence.com/download-sample/nicotine-patch-market
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: [email protected]
Tel: +1 877 441 4866
Website: www.datamintelligence.com